48MO SQZ-PBMC-HPV-101: Preliminary results of a first-in-human, dose-escalation study of a cell-based vaccine in HLA A*02+ patients with recurrent, locally advanced, or metastatic HPV16+ solid tumors
Titel:
48MO SQZ-PBMC-HPV-101: Preliminary results of a first-in-human, dose-escalation study of a cell-based vaccine in HLA A*02+ patients with recurrent, locally advanced, or metastatic HPV16+ solid tumors
Auteur:
Park, J-C. Baranda, J.C. Mita, M.M. Iams, W.T. Gordon, M.S. Taylor, M. Dhani, N. Loughhead, S.M. Ji, R-R. Zwirtes, R.F. Kornacker, M. Rosen, O. Bernstein, H. Jimeno, A.